Session: Hepatitis (IDWeek 2012 Meeting)

Friday, October 19, 2012: 12:30 PM-2:00 PM

Room: SDCC Poster Hall F-H

Topical Category: C. Clinical Studies and V. Clinical Virology

Tracks: Adult ID, Pediatric ID

Presentations:

1011	Responsiveness of Interferon Therapy Pediatric Age Group with Chronic Hepatitis B Infection Kai Lin, MD MS ; Tianjiao Yang, MD ; Yi Lu, MD ; Yanfeng Zhu, MD ; Xinbao Xie ; Xiaohong Wang, MD ; Qirong Zhu, MD ; Ting Zhang, MD PhD ; Hui Yu, MD PhD

1012	Staging HCV Disease in the Chronic Hepatitis Cohort Study (CHeCS) Scott Holmberg, MD, MPH ; Mei Lu, PhD ; Lora Rupp, MSE, MBA ; Anne Moorman, BSN, MPH ; Stuart C. Gordon, MD Posters Holmberg Poster IDWeek 12 CHeCS APRI FIB4.pdf (903.8 kB)

1013

Community Knowledge and Attitudes Regarding HCV Disease, Testing, and Treatment Among a High-risk Urban Population
Brianna L. Norton, DO ; Sarah H. Timberlake ; Emily J. Hecker, RN, MSN ; Neela D. Goswami, MD ; Kim M. Huffman, MD, PhD ; Anneka M. Landgraf ; Corrine I. Voils, PhD ; Susanna Naggie, MD ; Jason Stout, MD, MHS, FIDSA

1014

Chronic hepatitis C patients who had complete viral suppression during pegylated interferon alpha-2b and ribavirin treatment were less likely to development hepatocellular carcinoma: A prospective study
Eiichi Ogawa, MD., PhD. ; Norihiro Furusyo, MD., PhD. ; Masayuki Murata, MD., PhD. ; Jun Hayashi, MD., PhD.

1015

Insulin resistance is the most important factor in virological relapse by chronic hepatitis C patients treated with pegylated interferon alpha-2b and ribavirin
Eiichi Ogawa, MD., PhD. ; Norihiro Furusyo, MD., PhD. ; Masayuki Murata, MD., PhD. ; Hiroaki Ikezaki, MD. ; Takeshi Ihara, MD. ; Takeo Hayashi, MD. ; Kazuhiro Toyoda, MD. ; Kyoko Okada, MD., PhD. ; Mosaburo Kainuma, MD., PhD. ; Jun Hayashi, MD., PhD.

1016	Describing the Burden of Hepatitis C (HCV) in a large public health care system; Initial response to the National Viral Hepatitis Action Plan Oluwatoyin Adeyemi, MD ; Britt Livak, MPH ; Amanda E Grasso, MPH

1017	The Changing Epidemiology and Patient Characteristics of Hepatitis Delta Virus Infection in South London, United Kingdom CY William Tong, MD ; Radha Asher, MRCP ; Ranjababu Kulasegaram, FRCP ; Mark Wilkinson, MD ; Terry Wong, MD Posters IDWeek poster HDV WT v1.4.jpg (906.6 kB)

1018

Incidence of and Risk Factors for Reactivation of Hepatitis B in a Cohort of Alaska Native Persons in the Inactive Phase of Chronic Hepatitis B
Rania A. Tohme, MD, MPH ; Lisa Bulkow, MS ; Chriss Homan, BS ; Susan Negus, RN ; Brenna Simons ; Brian McMahon, MD

Posters

Tohme_IDSA 2012 poster.pdf (377.0 kB)

1019	Age is the most important risk of hepatocellular carcinoma after sustained virological responders to antiviral treatment for chronic hepatitis C Norihiro Furusyo, MD., PhD. ; Eiichi Ogawa, MD., PhD. ; Masayuki Murata, MD., PhD. ; Jun Hayashi, MD., PhD.

1020	Pegylated interferon alpha-2b plus ribavirin treatment reduces recurrence of hepatocellular carcinoma for chronic hepatitis C patients with history of hepatocellular carcinoma Norihiro Furusyo, MD., PhD. ; Eiichi Ogawa, MD., PhD. ; Masayuki Murata, MD., PhD. ; Jun Hayashi, MD., PhD.

1021	Hepatitis A Virus Infection in Food Handlers in the United States, 1993-2011 Karine Kentenyants, MD, MPH ; Umid M. Sharapov, MD, MSc ; Justina Groeger, MPH ; Scott Holmberg, MD, MPH

1022	Missed Opportunities in the Management of Chronic Hepatitis B Misha Huang, MD ; William Burman, MD ; Kirsten Wall, MHS ; Robert Beum, CCP Posters Hep B poster-36x56_final.pdf (454.2 kB)

1023	Chronic Viral Hepatitis B and C Nanuli Ninashvili, MD., PH.D ; Irakli Mchedlishvili

1024

Hospitalizations and Deaths among Acute Hepatitis B and C Cases Reported from U.S Enhanced Surveillance Sites, 2006-2010
Kashif Iqbal, MPH ; Monina Klevens, DDS, MPH ; Jennifer Baumgartner ; Elena M. Rizzo, MA ; Sue Speers ; Kristin Sweet ; Ann Thomas, MD, MPH ; Candace W Vonderwahl, BS

Posters

12_CS_234374_HEPATITIS B AND C POSTER 2 101012.pdf (8.2 MB)

1025	Personalized Learning: A Novel Educational Model to Bridge Clinical Practice Gaps in Chronic HBV Infection Nancy Reau, MD ; Susan Smith, MN, PhD ; Wendy Cerenzia, MS ; Simi Hurst, PhD Posters HBV-PL-poster_Final.pdf (842.8 kB)

1026	A Model for HCV Care Delivery in a US Non-Governmental Medically Indigent Care Setting Todd Wills, MD ; Dorothy Lindsay, RN Posters ID Week Poster 1026.pdf (354.5 kB)

1027	Assessment of Clinician Practices in Screening and Linkage to Care for Chronic Hepatitis B Melissa Osborn, MD ; Yelena Lyustikman, MS ; Wendy Cerenzia, MS ; Jennifer J Brown, PhD ; Simi Hurst, PhD

1028	Treating HIV/HCV Co-infection: Experiences from an Inner City Clinic Paula Dilanchian, DO ; Khaled Deeb, PhD, MBA ; Kanwal Razzaq, MD ; Dushyantha Jayaweera, MD, MRCOG, FACP

CME Credits:

See more of: Poster Abstract Session

<< Previous Session | Next Session >>